Most people who reach the point of asking what comes after an antidepressant have already put real effort into their care. They have taken medicine, shown up for appointments, and tried to be patient. When the mood still does not lift the way everyone hoped, it is natural to feel that the plan has failed. It helps to know that a stalled medication is information, not a verdict on you or on the whole idea of treatment.
Clinicians tend to look at the next move as a set of choices rather than a ladder with a single correct rung. Some choices adjust what is already in place, such as changing the dose, switching to a different medication, or adding a medicine that works alongside the current one. Others change the kind of treatment altogether. Talk therapy, brain stimulation, and newer medicines that act on a different system all belong to that wider group. Which one fits depends on what has been tried already, how symptoms have shown up, which side effects were hard to live with, and what your daily life can realistically support.
What the Doctor Is Weighing
When a clinician talks through options, several questions usually sit underneath the conversation. How long did the earlier treatment run, and at what dose? Was the medicine taken as prescribed, or did life get in the way? Did you notice any improvement at all, even a small one, that faded later? Did side effects make you want to stop? Each of those answers changes the picture. A treatment that gave partial relief might be adjusted rather than abandoned. A treatment that caused problems you could not tolerate points somewhere else.
Insurance rules and access also matter, though they often feel like background noise. Some plans want earlier steps documented before they will cover a particular option, and the clinic's office staff may know those rules better than anyone. Asking the clinician directly which options are realistic for your coverage and location keeps the conversation grounded.
Your own goals belong in this weighing too. Some people care most about getting through the workday with less effort. Others are focused on sleep, appetite, or being present with family. Saying what matters most helps the clinician sort options by how well they match your life, not only by what sounds most advanced.
Understanding the Options in Plain Terms
Known as TMS for short, transcranial magnetic stimulation applies magnetic impulses to a specific patch of the scalp. Appointments take place in a medical office, the patient remains conscious, and the sessions are spread across several weeks. The biggest demand is a commitment of time and showing up consistently. Patients commonly report a tapping feeling during sessions, and fitting the timetable around employment or caring for children is often the toughest challenge.
Ketamine-family treatments and esketamine nasal spray work differently and are usually given in a clinic under close supervision. Esketamine is offered under its REMS program, a set of federal rules that govern how it is prescribed and where it can be given. These treatments bring their own practical demands, such as arranging a ride home, since alertness is affected for a period after each dose. Your clinician can explain how the logistics would look in your situation.
Talk therapy is also part of the conversation for many people. Some clinicians recommend adding structured therapy to medication, while others suggest it as a standalone option or as support during a change in medicine. Therapy does not replace the medical side of care, but it can build skills and give you a place to process what is happening.
None of these choices is automatically better than the others. The research on each varies in strength and in what it can and cannot show, and a clinician who is honest with you will say so. Being wary of promises is a sensible stance.
Making the Next Step Feel Workable
A few habits make this stage less overwhelming. Write down what you tried, roughly how long each try lasted, and what changed, good or bad. Bring that list to the visit. Ask what the clinician expects to see from the next option and how soon, so you know what checkpoints to watch. Ask what would make them change course if the new approach is not working. Those questions keep the plan open to revision.
It also helps to say plainly how you have been doing with the current plan, including the parts you are not proud of. Skipped doses, mixed feelings about medicine, or wanting to give up are useful details, not failures to hide. Clinicians can only choose well from the picture they are given.
If starting something new feels overwhelming, it is also worth acknowledging that feeling. Fatigue during treatment happens often, and it says nothing about whether you still want to recover. At times, a smaller and more doable first move, selected together with the clinician, is the most helpful thing, and progress can grow from there.